The Power of AI to Improve Clinical Trial Monitoring
Artificial intelligence is reshaping how clinical trials are monitored — but its application to clinical...Continue reading→
TMF with Dawn Niccum
Your Trial Master File is not just a compliance requirement — it's the story of...Continue reading→
The People at inSeption
What makes a team genuinely good to work with? For Kelly, it comes down to...Continue reading→
Beyond Fractional with Steve Zelenkofske
Steve Zelenkofske has watched emerging biotech companies try to solve the same resourcing problem two...Continue reading→
The Scaffolding Approach to Trial Rescue
When a clinical trial is in trouble, the instinct is often to tear everything down...Continue reading→
Quality Assurance with Dawn Niccum
The best time to find a problem in your QA program is before FDA finds...Continue reading→
IND Capabilities with Angela Thompson
You've done the science. You know your protocol. But now you're staring at a barrage...Continue reading→
Meet Sara McCradden
Sara McCradden came to inSeption because she wanted her advice to actually matter — grounded...Continue reading→
Steve Zelenkofske on Control
When you hand a clinical program off entirely, you don't just delegate—you abdicate. That's the...Continue reading→
Do It Yourself With Us
The clinical outsourcing industry was built for a world of 20,000-patient trials. That world is...Continue reading→
How To Build Strategic Readiness For First-In-Human Studies
Moving from IND submission to first patient enrollment requires more than regulatory approval — it...Continue reading→
Charting the Path to First-in-Human Studies: Strategic Planning for Early Clinical Success
The transition to first-in-human studies is one of the most significant and challenging stages in...Continue reading→
inSpired by Noelle
When Rare Becomes Personal: Noelle’s Story of Advocacy, Survival, and Purpose In October 2019, Noelle...Continue reading→
What to Look for in a Strategic Partner
Ed Tucker, MD MBA shares his perspective on what to look for in a strategic...Continue reading→
Avoid the Wrecking Ball: Targeted Solutions for Struggling Trials
When clinical trials begin to veer off course, the instinctive response is often to “rescue”...Continue reading→
Fixing the Monitoring Model: How a Flexible Resource Supports Trial Success
As clinical trials become more complex, traditional monitoring models are increasingly difficult to sustain. Rigid...Continue reading→
Press Release for the SQA Board of Directors
FOR IMMEDIATE RELEASE inSeption Group Congratulates Dawn Niccum on Election to the SQA Board of...Continue reading→
Founders Forward Focus Forum: Interview with Joe Arcangelo
If you want a real look into what drives InSeption Group’s culture, values, and long-term...Continue reading→
Streamlining Clinical Data Management
In clinical development, data management should be a strategic advantage — not a bottleneck. Yet...Continue reading→
Regulatory Submission Crisis Rescue
In today’s highly competitive development landscape, a regulatory submission can unravel quickly—and often long before...Continue reading→
Philadelphia Business Journal Thought Leadership: Life Sciences
We’re proud to share that Robin Johnson, PharmD, Gene Therapy Submissions Lead at inSeption Group,...Continue reading→